$257 Million is the total value of Canaan Partners X LLC's 4 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASTR | Sell | Astra Space Inc | $114,273,000 | -36.4% | 16,489,668 | -20.3% | 44.55% | -13.0% |
| Berkshire Grey Inc | $78,664,000 | -21.8% | 14,302,523 | 0.0% | 30.67% | +7.1% | ||
| IDYA | IDEAYA Biosciences Inc | $62,899,000 | -7.3% | 2,660,713 | 0.0% | 24.52% | +27.0% | |
| ITRM | Iterum Therapeutics plc | $679,000 | -29.8% | 1,733,170 | 0.0% | 0.26% | -3.6% | |
| NXTC | Exit | NextCure Inc | $0 | – | -321,647 | -100.0% | -0.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IDEAYA Biosciences Inc | 16 | Q3 2023 | 96.1% |
| Iterum Therapeutics plc | 12 | Q3 2022 | 6.0% |
| NextCure Inc | 8 | Q3 2021 | 82.8% |
| Berkshire Grey Inc | 8 | Q2 2023 | 41.8% |
| Astra Space Inc | 4 | Q2 2022 | 51.2% |
| MONEYLION INC | 2 | Q3 2023 | 3.9% |
View Canaan Partners X LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-10-11 |
| 13F-HR | 2023-07-13 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-04-28 |
| 13F-HR | 2022-02-03 |
| 4 | 2022-01-04 |
| 13F-HR | 2021-11-15 |
View Canaan Partners X LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.